Dr. Mary Jue Xu, MD

Dr. Xu practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Xu's NPI, 1457713281, was assigned on March 22, 2016. Dr. Xu graduated from Harvard Medical School in 2016. Dr. Xu holds California license A154104.

Dr. Xu's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Xu's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. Dr. Xu is also affiliated with Zuckerberg San Francisco General Hospital and Trauma Center. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Xu to 4 more group practices and clinics and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Xu practices, 6 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Xu's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Xu is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Xu's licenses on file in 2 states: California and Pennsylvania.

Dmand AI lists thyroid surgery among the conditions Dr. Xu treats.

CMS data shows 114 Medicare services from Dr. Xu across 5 procedure codes in 2024, for 66 Medicare patients. Medicare paid $5,671 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 66 Medicare patients who saw Dr. Xu in 2024. The largest group is 65 to 74, with 28 patients. 75% of them have high blood pressure, and 61% have high cholesterol. 62% are also on Medicaid. Their average risk score is 2.16, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Xu's median patient age at 71, with 35% women.

In 2024, Dr. Xu wrote 80 Medicare Part D claims for 23 patients. 98% of them were for generic drugs. CMS names the drug for 36 of them, across 2 drugs with 11 or more claims each, at $254 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Xu for performance year 2024, reported as part of a group. Dr. Xu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Xu as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 33 papers to Dr. Xu, published from 2009 to 2025. 2023 was the busiest year, with 5. The most frequent topics are Otolaryngology, Head and Neck Neoplasms and Carcinoma, Squamous Cell. Dr. Xu has published most often in Laryngoscope. Dr. Xu's most frequent co-authors are Blake C. Alkire, MD, Patrick Ha, MD and Ivy Maina, MD.

CMS Open Payments shows 21 general payments to Dr. Xu from 15 drug and device companies from 2021 to 2025. Education make up the largest share, 45% of the total. Intuitive Surgical, Inc. paid the most, $1,271.

Dr. Xu graduated from Harvard Medical School in 2016. Dr. Xu is a member of NHS.

Dr. Xu is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Horizon Blue Cross Blue Shield of New Jersey. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.